Journal of Global Pharma Technology
Volume 11 Issue 04.

Hematologic and Clinical Features of Thalassemia Patients with Early or Late Onset Transfusion in East Java, Indonesia

Retno Dwi Wulandari (Unknown)



Article Info

Publish Date
16 Nov 2016

Abstract

Thalassemia is a genetic disorder of hemoglobin production which causes chronic anemia. Complete blood count showed lower HbA, MCV, MCH, increase RDW-CV and increase HbA2 (>3,5%) and HbF (>1,5%). Thalassemia major patients need regular and lifelong blood transfusion which started early in life. Thalassemia intermedia, usually with milder symptoms, require blood transfusion at later age, with lower transfusion rate. This study aims to compare hematologic, HbA2 and HbF profiles as well as height, weight, Body Mass Index and spleen size in thalassemia patients grouped based on transfusion start whether in early or later age (before or after 10 yo). Results showed that the hematologic, HbA2 and HbF profiles were not significantly different in both groups. The clinical profiles i.e. Height and weight were below 3rd percentile in both groups; low BMI and more patients underwent splenectomy in group of those with early onset blood transfusion.Keywords: Thalassemia, Transfusion, Hematologic, Height, Weight, BMI.

Copyrights © 2016






Journal Info

Abbrev

jgpt

Publisher

Subject

Medicine & Pharmacology

Description

ournal of Global Pharma Technology is a monthly, open access, Peer review journal of Pharmacy published by JGPT Journal publishes peer-reviewed original research papers, case reports and systematic reviews. The journal allows free access to its contents, which is likely to attract more readers and ...